ici 153066 has been researched along with bay h 4502 in 2 studies
| Studies (ici 153066) | Trials (ici 153066) | Recent Studies (post-2010) (ici 153066) | Studies (bay h 4502) | Trials (bay h 4502) | Recent Studies (post-2010) (bay h 4502) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 305 | 49 | 67 |
| Protein | Taxonomy | ici 153066 (IC50) | bay h 4502 (IC50) |
|---|---|---|---|
| phospholipase A2 precursor | Homo sapiens (human) | 8.89 | |
| cysteine protease ATG4B isoform a | Homo sapiens (human) | 8.5 | |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Homo sapiens (human) | 0.79 | |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.342 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cauwenbergh, G | 1 |
| Espinel-Ingroff, A; Kerkering, TM; Shadomy, S | 1 |
2 other study(ies) available for ici 153066 and bay h 4502
| Article | Year |
|---|---|
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
Topics: Antifungal Agents; Arthrodermataceae; Blastomyces; Candida; Coccidioides; Cryptococcus neoformans; Drug Evaluation, Preclinical; Histoplasma; Imidazoles; Ketoconazole; Miconazole; Morpholines; Sporothrix; Triazoles | 1984 |